December 24th 2024
Pregnant women infected with avian influenza face a 90% maternal and 86% infant mortality rate, underscoring the urgent need for pandemic preparedness and protection strategies.
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Cleveland Clinic reexamines syphilis testing strategies after rise in cases
February 7th 2023After observing an increase in the rate of syphilis cases, the Cleveland Clinic Ob/Gyn & Women’s Health Institute has partnered with the Center for Pediatric Infectious Diseases to evaluate the effectiveness of current testing strategies.
Bacterial vaginosis during pregnancy may heighten risk of preterm birth, pregnancy loss
November 28th 2022Bacterial vaginosis during pregnancy may lead to increased risks for preterm birth, preterm delivery, and spontaneous abortion, according to new research in the Archives of Gynecology and Obstetrics.
Disparities in prenatal health of infants conceived by assisted reproduction
November 7th 2022Racial and ethnic disparities in adverse perinatal outcomes were significantly greater among women who used medically assisted reproduction (MAR) than those who conceived spontaneously, according to a study published in the journal Pediatrics.
Caring for the gynecologic needs of the adolescent patient
October 4th 2022In a recent presentation at at the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Conference, Carri Holton, MSN, WHNP, discussed gynecological complications that adolescents may face and offered practical treatment options.
FDA accepts sNDA for review of Myfembree in uterine fibroid treatment
June 13th 2022The FDA recently announced the acceptance of a supplemental New Drug Application for relugolix 40 mg, estradiol 1 mg, and norethindrone acetate .5 mg in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.